Voyager Therapeutics, Inc. financial data

Symbol
VYGR on Nasdaq
Location
Lexington, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 579% % -14%
Debt-to-equity 31% % -13%
Return On Equity -49% % -688%
Return On Assets -37% % -708%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55,600,084 shares 1.8%
Common Stock, Shares, Outstanding 55,482,262 shares 1.7%
Entity Public Float $407,600,000 USD -17%
Common Stock, Value, Issued $56,000 USD 1.8%
Weighted Average Number of Shares Outstanding, Basic 58,803,015 shares 1.6%
Weighted Average Number of Shares Outstanding, Diluted 58,803,015 shares 1.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $31,316,000 USD -81%
Research and Development Expense $134,305,000 USD 14%
General and Administrative Expense $37,222,000 USD 0.14%
Operating Income (Loss) $140,211,000 USD -1645%
Nonoperating Income (Expense) $14,148,000 USD -20%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $126,063,000 USD -571%
Income Tax Expense (Benefit) $719,000 USD -20%
Net Income (Loss) Attributable to Parent $126,782,000 USD -590%
Earnings Per Share, Basic -2 USD/shares -466%
Earnings Per Share, Diluted -2 USD/shares -466%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $45,125,000 USD -60%
Marketable Securities, Current $163,805,000 USD -30%
Cash, Cash Equivalents, and Short-term Investments $229,000,000 USD -34%
Other Assets, Current $2,874,000 USD 9.4%
Assets, Current $219,585,000 USD -41%
Property, Plant and Equipment, Net $13,291,000 USD -13%
Operating Lease, Right-of-Use Asset $29,740,000 USD -14%
Assets $288,311,000 USD -32%
Accounts Payable, Current $2,116,000 USD -33%
Employee-related Liabilities, Current $6,218,000 USD 4.9%
Accrued Liabilities, Current $14,953,000 USD 31%
Contract with Customer, Liability, Current $10,578,000 USD -53%
Liabilities, Current $35,495,000 USD -20%
Contract with Customer, Liability, Noncurrent $1,471,000 USD -88%
Operating Lease, Liability, Noncurrent $30,520,000 USD -20%
Other Liabilities, Noncurrent $37,499,000 USD 107%
Liabilities $68,486,000 USD -28%
Accumulated Other Comprehensive Income (Loss), Net of Tax $7,000 USD
Retained Earnings (Accumulated Deficit) $418,479,000 USD -43%
Stockholders' Equity Attributable to Parent $219,825,000 USD -33%
Liabilities and Equity $288,311,000 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $37,895,000 USD -164%
Net Cash Provided by (Used in) Financing Activities $82,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $41,201,000 USD
Common Stock, Shares Authorized 120,000,000 shares 0%
Common Stock, Shares, Issued 55,482,262 shares 1.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,388,000 USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $50,739,000 USD -56%
Deferred Tax Assets, Valuation Allowance $105,854,000 USD 28%
Deferred Tax Assets, Gross $117,717,000 USD 32%
Operating Lease, Liability $38,368,000 USD
Depreciation $1,014,000 USD -15%
Payments to Acquire Property, Plant, and Equipment $658,000 USD -69%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $126,742,000 USD -586%
Lessee, Operating Lease, Liability, to be Paid $45,178,000 USD
Property, Plant and Equipment, Gross $30,272,000 USD -4%
Operating Lease, Liability, Current $7,848,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,763,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $9,983,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,810,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,996,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $4,244,000 USD -69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,235,000 USD
Additional Paid in Capital $638,241,000 USD 2.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $11,863,000 USD 85%
Share-based Payment Arrangement, Expense $15,002,000 USD 6.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%